Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Striae Distensae
Interventions
DRUG

Poly-L Lactic Acid

After initial treatment, reassessment will be conducted at 3 follow-up visits. Photographs will be taken for blinded evaluators to compare post-treatment to the original pre-treatment photographs. At final visit, a questionnaire will be administered to rate treatment satisfaction.

DEVICE

Fractional laser treatment

After initial treatment, reassessment will be conducted at 3 follow-up visits. Photographs will be taken for blinded evaluators to compare post-treatment to the original pre-treatment photographs. At final visit, a questionnaire will be administered to rate treatment satisfaction.

Trial Locations (1)

48202

Henry Ford Health System, Detroit

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Galderma R&D

INDUSTRY

lead

Henry Ford Health System

OTHER

NCT03858543 - Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae | Biotech Hunter | Biotech Hunter